Kseniya N. Sedenkova

Dr. Kseniya N. Sedenkova

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2019 in MedChemComm
Verified
Journal Article
Closed access
PDF file
ANAnna A. Nazarova
Anna A. Nazarova
KSKseniya N. Sedenkova
Kseniya N. Sedenkova
DKDmitry S. Karlov
Dmitry S. Karlov
MLMstislav I. Lavrov
Mstislav I. Lavrov
YGYuri K. Grishin
Yuri K. Grishin
VPVladimir Palyulin
Vladimir Palyulin
Bis(tetrahydroquinazolines) potentiate kainate-induced currents at 10−12–10−8M.

31 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
KSKseniya N. Sedenkova
Kseniya N. Sedenkova
KAKristian S. Andriasov
Kristian S. Andriasov
MEMarina G. Eremenko
Marina G. Eremenko
YGYuri Grishin
Yuri Grishin
VAVera A. Alferova
Vera A. Alferova
EAElena Averina
Elena Averina
The application of non-planar scaffolds in drug design allows for the enlargement of the chemical space, and for the construction of molecules that have more effective target–ligand interactions or are less prone to the development of resistance. Among the works of the last decade, a literature search revealed spirothiazamenthane, which has served as a lead in the development of derivatives active against resistant viral strains. In this work, we studied the novel molecular scaffold, which resembles spirothiazamenthane, but combines isoxazoline as a heterocycle and cyclooctane ring as a hydrophobic part of the structure. The synthesis of new 3-nitro- and 3-aminoisoxazolines containing spiro-fused or 1,2-annelated cyclooctane fragments was achieved by employing 1,3-dipolar cycloaddition of 3-nitro-4,5-dihydroisoxazol-4-ol 2-oxide or tetranitromethane-derived alkyl nitronates with non-activated alkenes. A series of spiro-sulfonamides was obtained by the reaction of 3-aminoisoxazoline containing a spiro-fused cyclooctane residue with sulfonyl chlorides. Preliminary screening of the compounds for antiviral, antibacterial, antifungal and antiproliferative properties in vitro revealed 1-oxa-2-azaspiro[4.7]dodec-2-en-3-amine and 3a,4,5,6,7,8,9,9a-octahydrocycloocta[d]isoxazol-3-amine with activity against the influenza A/Puerto Rico/8/34 (H1N1) virus in the submicromolar range, and high values of selectivity index. Further study of the mechanism of the antiviral action of these compounds, and the synthesis of their analogues, is likely to identify new agents against resistant viral strains.

23 October 2021 in Molecules
Verified
Journal Article
Open access
PDF file
DVDmitry A. Vasilenko
Dmitry A. Vasilenko
KSKirill S. Sadovnikov
Kirill S. Sadovnikov
KSKseniya N. Sedenkova
Kseniya N. Sedenkova
DKDmitry S. Karlov
Dmitry S. Karlov
EREugene V. Radchenko
Eugene V. Radchenko
EAElena Averina
Elena Averina
A convenient synthetic approach to novel functionalized bis(isoxazoles), the promising bivalent ligands of the AMPA receptor, was elaborated. It was based on the heterocyclization reactions of readily available electrophilic alkenes with the tetranitromethane-triethylamine complex. The structural diversity of the synthesized compounds was demonstrated. In the electrophysiological experiments using the patch clamp technique on Purkinje neurons, the compound 1,4-phenylenedi(methylene)bis(5-aminoisoxazole-3-carboxylate) was shown to be highly potent positive modulator of the AMPA receptor, potentiating kainate-induced currents up to 70% at 10−11 M.

1 May 2019 in Dyes and Pigments
Verified
Journal Article
Closed access
KSKseniya N. Sedenkova
Kseniya N. Sedenkova
JKJulia V. Kolodyazhnaya
Julia V. Kolodyazhnaya
DVDmitry A. Vasilenko
Dmitry A. Vasilenko
YGYulia A. Gracheva
Yulia A. Gracheva
EKElena V. Kharitonoshvili
Elena V. Kharitonoshvili
EAElena Averina
Elena Averina

21 October 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KSKseniya N. Sedenkova
Kseniya N. Sedenkova
DLDenis N. Leschukov
Denis N. Leschukov
YGYuri Grishin
Yuri Grishin
NZNikolay A. Zefirov
Nikolay A. Zefirov
YGYulia A. Gracheva
Yulia A. Gracheva
EAElena Averina
Elena Averina
Tubulin-targeting agents attract undiminished attention as promising compounds for the design of anti-cancer drugs. Verubulin is a potent tubulin polymerization inhibitor, binding to colchicine-binding sites. In the present work, a series of verubulin analogues containing a cyclohexane or cycloheptane ring 1,2-annulated with pyrimidine moiety and various substituents in positions 2 and 4 of pyrimidine were obtained and their cytotoxicity towards cancer and non-cancerous cell lines was estimated. The investigated compounds revealed activity against various cancer cell lines with IC50 down to 1–4 nM. According to fluorescent microscopy data, compounds that showed cytotoxicity in the MTT test disrupt the normal cytoskeleton of the cell in a pattern similar to that for combretastatin A-4. The hit compound (N-(4-methoxyphenyl)-N,2-dimethyl-5,6,7,8-tetrahydroquinazolin-4-amine) was encapsulated in biocompatible nanocontainers based on Ca2+ or Mg2+ cross-linked alginate and it was demonstrated that its cytotoxic activity was preserved after encapsulation.

26 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
KSKseniya N. Sedenkova
Kseniya N. Sedenkova
DZDenis V. Zverev
Denis V. Zverev
ANAnna A. Nazarova
Anna A. Nazarova
MLMstislav I. Lavrov
Mstislav I. Lavrov
EREugene V. Radchenko
Eugene V. Radchenko
VPVladimir Palyulin
Vladimir Palyulin
Positive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AMPA receptor’s allosteric binding site. In the present work, novel bis(pyrimidines) were studied as AMPA receptor modulators. A convenient and flexible preparative approach to bis(pyrimidines) containing a hydroquinone linker was elaborated, and a series of derivatives with varied substituents was obtained. The compounds were examined in the patch clamp experiments for their influence on the kainate-induced currents, and 10 of them were found to have potentiating properties. The best potency was found for 2-methyl-4-(4-((2-methyl-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)phenoxy)-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine, which potentiated the kainate-induced currents by up to 77% in all tested concentrations (10−12–10−6 M). The results were rationalized via the modeling of modulator complexes with the dimeric ligand binding domain of the GluA2 AMPA receptor, using molecular docking and molecular dynamics simulation. The prediction of ADMET, physicochemical, and PAINS properties of the studied bis(pyrimidines) confirmed that PAMs of this type may act as the potential lead compounds for the development of neuroprotective drugs.